Bcl-2 and Bax produce opposing effects in the regulation of cell apoptosis [13], and the proportion of Bcl-2 and Bax protein determines whether cells survive or undergo apoptosis, which in turn influences the therapeutic effects of different cancer treatments [14]. The gene discussed is BAX; the disease is cancer.